Sean P. Nolan

Insider Reports History

Entity
Individual
Location
C/O Intermune, Inc., 3280 Bayshore Blvd., Brisbane, CA
Signature
Sean P. Nolan, By: /s/ Kenneth Hagan, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sean P. Nolan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Taysha Gene Therapies, Inc. Chief Executive Officer, Director Common Stock 1.54M $2.5M $1.63 Jan 2, 2024 Indirect
Taysha Gene Therapies, Inc. Chief Executive Officer, Director Common Stock 1.19M $1.93M $1.63 Jan 2, 2024 Direct
Ventas, Inc. Director Common Stock 21.3K $1.02M $47.96 May 14, 2024 Direct
Taysha Gene Therapies, Inc. Chief Executive Officer, Director Employee Stock Option (right to buy) 1.18M Jan 2, 2024 Direct

Insider Reports Filed by Sean P. Nolan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VTR Ventas, Inc. May 14, 2024 1 $175K 4 May 16, 2024 Director
TSHA Taysha Gene Therapies, Inc. Jan 2, 2024 2 $0 4 Jan 4, 2024 Chief Executive Officer, Director
TSHA Taysha Gene Therapies, Inc. Dec 14, 2023 1 $0 4 Dec 18, 2023 Chief Executive Officer, Director
TSHA Taysha Gene Therapies, Inc. Aug 16, 2023 1 $400K 4 Aug 16, 2023 Chief Executive Officer, Director
VTR Ventas, Inc. May 16, 2023 1 $175K 4 May 18, 2023 Director
TSHA Taysha Gene Therapies, Inc. Dec 30, 2022 1 $0 4 Jan 4, 2023 Chief Executive Officer, Director
TSHA Taysha Gene Therapies, Inc. Jun 17, 2022 1 $0 4 Jun 22, 2022 Director
VTR Ventas, Inc. Apr 27, 2022 1 $175K 4 Apr 29, 2022 Director
DNAB Social Capital Suvretta Holdings Corp. II Sep 24, 2021 0 $0 3 Sep 24, 2021 Director
TSHA Taysha Gene Therapies, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director
VTR Ventas, Inc. May 25, 2021 1 $0 4 May 27, 2021 Director
TSHA Taysha Gene Therapies, Inc. May 20, 2021 1 $26.1K 4 May 24, 2021 Director